- Home
- DOCN vs APLS Comparison
DOCN vs APLS Comparison
Compare DOCN & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCN
- APLS
- Stock Information
- Founded
- DOCN 2011
- APLS 2009
- Country
- DOCN United States
- APLS United States
- Employees
- DOCN N/A
- APLS N/A
- Industry
- DOCN Retail: Computer Software & Peripheral Equipment
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- DOCN Technology
- APLS Health Care
- Exchange
- DOCN Nasdaq
- APLS Nasdaq
- Market Cap
- DOCN 2.5B
- APLS 2.2B
- IPO Year
- DOCN 2021
- APLS 2017
- Fundamental
- Price
- DOCN $28.24
- APLS $19.35
- Analyst Decision
- DOCN Buy
- APLS Buy
- Analyst Count
- DOCN 14
- APLS 19
- Target Price
- DOCN $40.62
- APLS $37.39
- AVG Volume (30 Days)
- DOCN 1.5M
- APLS 1.8M
- Earning Date
- DOCN 08-05-2025
- APLS 07-31-2025
- Dividend Yield
- DOCN N/A
- APLS N/A
- EPS Growth
- DOCN 119.67
- APLS N/A
- EPS
- DOCN 1.14
- APLS N/A
- Revenue
- DOCN $806,588,000.00
- APLS $775,839,000.00
- Revenue This Year
- DOCN $15.19
- APLS $1.01
- Revenue Next Year
- DOCN $13.99
- APLS $22.14
- P/E Ratio
- DOCN $24.84
- APLS N/A
- Revenue Growth
- DOCN 13.21
- APLS 48.04
- 52 Week Low
- DOCN $25.45
- APLS $16.10
- 52 Week High
- DOCN $47.02
- APLS $42.47
- Technical
- Relative Strength Index (RSI)
- DOCN 46.63
- APLS 59.31
- Support Level
- DOCN $28.66
- APLS $17.35
- Resistance Level
- DOCN $30.37
- APLS $19.63
- Average True Range (ATR)
- DOCN 0.94
- APLS 0.76
- MACD
- DOCN 0.16
- APLS 0.19
- Stochastic Oscillator
- DOCN 41.02
- APLS 93.47
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.